Analyst fair value for Boston Scientific has shifted from US$75.00 to US$72.25, pointing to a modest reset in price targets.
DaVita’s modeled fair value has shifted from US$193.71 to US$208.57, signaling a fresh round of updated price targets that ...
Spread the loveWhen you think about creating presentations, certain software names probably spring to mind immediately.
Spread the loveIn a world where digital productivity suites are as common as your morning coffee, it takes something special ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results